Virtual clinical trials: A tool for predicting patients who may benefit from treatment beyond progression with pembrolizumab in non‐small cell lung cancer-Reference-Cited by-同舟云学术

Virtual clinical trials: A tool for predicting patients who may benefit from treatment beyond progression with pembrolizumab in non‐small cell lung cancer

Published:2022-12-22 Issue:2 Volume:12 Page:236-249
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacom & Syst Pharma

Author:

Qi Timothy¹^ORCID,Cao Yanguang¹²

Affiliation:

1. Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy The University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

2. Lineberger Comprehensive Cancer Center The University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12896

Reference32 articles.

1. Feasibility of Cancer Clinical Trial Enrollment Goals Based on Cancer Incidence

2. Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

3. Lesion-Level Response Dynamics to Programmed Cell Death Protein (PD-1) Blockade

4. Lesion-level heterogeneity of radiologic progression in patients treated with pembrolizumab

5. Beyond the single average tumor: Understanding IO combinations using a clinical QSP model that incorporates heterogeneity in patient response

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Digital twins for health: a scoping review;npj Digital Medicine;2024-03-22

2. In silico trial for the assessment of givinostat dose adjustment rules based on the management of key hematological parameters in polycythemia vera patients;CPT: Pharmacometrics & Systems Pharmacology;2024-02-07

3. Artificial intelligence across oncology specialties: current applications and emerging tools;BMJ Oncology;2024-01

4. Realizing the Promise of Project Optimus: Challenges and Emerging Opportunities for Dose Optimization in Oncology Drug Development;CPT: Pharmacometrics & Systems Pharmacology;2023-11-15

5. Jumeaux numériques : futur de la médecine personnalisée en cancérologie;Bulletin du Cancer;2023-10